Wolverine stack protocol: PDA: 500 mcg to 1 mg subcutaneous, once daily TB-500: 2.0 to 2.5 mg subcutaneous, 2 to 3 times weekly (loading phase), then once weekly (maintenance) Duration: 6 to 8 weeks Timing: PDA and TB-500 can be administered at the same time or at different times during the day
As we age, natural levels of GHK-Cu decline, which can contribute to slower healing, loss of skin elasticity, and visible signs of aging
Both are on the July 2026 Pharmacy Compounding Advisory Committee agenda for 503A compounding review, which is a separate regulatory question from approval
When its done by a trained professional, youll absorb it better, see results faster, and avoid unnecessary side effects
The Safety Profile: Are Injections Safe